Novel rat Alzheimer's disease models based on AAV-mediated gene transfer to selectively increase hippocampal Aβ levels
Open Access
- 1 January 2007
- journal article
- Published by Springer Nature in Molecular Neurodegeneration
- Vol. 2 (1) , 11
- https://doi.org/10.1186/1750-1326-2-11
Abstract
No abstract availableKeywords
This publication has 64 references indexed in Scilit:
- Aβ42 Is Essential for Parenchymal and Vascular Amyloid Deposition in MiceNeuron, 2005
- What is the dominant aβ species in human brain tissue? A reviewNeurotoxicity Research, 2005
- Aβ is targeted to the vasculature in a mouse model of hereditary cerebral hemorrhage with amyloidosisNature Neuroscience, 2004
- The Amyloid Hypothesis of Alzheimer's Disease: Progress and Problems on the Road to TherapeuticsScience, 2002
- Time Course of the Development of Alzheimer-like Pathology in the Doubly Transgenic PS1+APP MouseExperimental Neurology, 2002
- Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenesNature Medicine, 1998
- Accelerated Amyloid Deposition in the Brains of Transgenic Mice Coexpressing Mutant Presenilin 1 and Amyloid Precursor ProteinsNeuron, 1997
- Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic MiceScience, 1996
- A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N–terminus of β–amyloidNature Genetics, 1992
- Early-onset Alzheimer's disease caused by mutations at codon 717 of the β-amyloid precursor protein geneNature, 1991